Ocular Therapeutix Inc

OCUL USD0.0001
Create an alert
Sell$10.42
Buy$10.43
$0.30 (2.75%)
Last updated today at
Back to dashboard

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
31 August 2026
Donald D. Jr NotmanCOO
Sell
Tax related
1,099$10.24$11,253.76366,529
24 August 2026
Pravin U DugelChairman/CEO
Sell
Tax related
21,649$10.77$233,159.732,525,429
24 August 2026
Sanjay NayakChief Level Officer
Sell
Tax related
1,897$10.78$20,449.66326,898
24 August 2026
Jeffrey S. (Jeff) HeierChief Level Officer
Sell
Tax related
3,296$10.78$35,530.88318,326
24 August 2026
Peter K KaiserChief Level Officer
Sell
Tax related
3,035$10.77$32,686.95264,378
3 June 2026
Nadia WaheedOther Level A
Sell
Regular sell transaction (market)
14,828$8.27$122,627.56300,079
26 May 2026
Pravin U DugelChairman/CEO
Sell
Tax related
21,156$8.20$173,479.202,597,170
26 May 2026
Sanjay NayakChief Level Officer
Sell
Tax related
1,858$8.20$15,235.60328,795
26 May 2026
Jeffrey S. (Jeff) HeierChief Level Officer
Sell
Tax related
3,018$8.20$24,747.60320,350
26 May 2026
Peter K KaiserChief Level Officer
Sell
Tax related
2,967$8.20$24,329.40266,141

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
12 February 2026
Pravin U DugelChairman/CEO
Sell
Tax related
124,882$9.04$1,128,933.283,033,078
20 February 2026
Richard L. LindstromIndependent Director
Buy
Regular purchase transaction
60,229$7.66$461,354.14246,933
5 November 2025
Namrata SarojChief Level Officer
Sell
Tax related
25,865$10.74$277,790.10174,135
24 November 2025
Pravin U DugelChairman/CEO
Sell
Tax related
19,530$12.04$235,141.203,157,960
24 August 2026
Pravin U DugelChairman/CEO
Sell
Tax related
21,649$10.77$233,159.732,525,429

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.